Elanco Announces Updates to Board of Directors

Board of Directors Update - Elanco Animal Health Incorporated announced that R. David Hoover and Deborah Kochevar will not stand for re-election at the 2026 Annual Meeting of Shareholders in May [1] - R. David Hoover, the founding Chairman, is retiring after joining the Board in September 2018, playing a crucial role during the company's IPO and initial years as a public entity [1] - Dr. Deborah Kochevar, who joined the Board in March 2019, is also concluding her service, having led the Innovation, Science and Technology committee [1] Leadership Contributions - Lawrence E. Kurzius, Chairman of the Board, praised Hoover's foundational leadership and strategic direction during Elanco's transformation into an independent company [1] - Jeff Simmons, Elanco President and CEO, credited Hoover's insights for positioning Elanco as a global leader and emphasized the company's strong future [1] - Kochevar's expertise in veterinary medicine was highlighted as critical for supporting Elanco's innovation pipeline and maintaining a culture of scientific excellence [1] Future Board Composition - Following the departures, the Board will consist of nine directors, indicating a streamlined governance structure [1]